Cytodyn Inc (CYDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 05/31
| 11-2021 | 08-2021 | 05-2021 | 02-2021 | 11-2020 | |
| Sales | 225 | 41 | 0 | 0 | 0 |
| Cost of Goods | 52 | 1 | N/A | N/A | 0 |
| Gross Profit | 173 | 40 | N/A | N/A | 0 |
| Operating Expenses | 25,547 | 21,678 | 23,740 | 30,785 | 24,503 |
| Operating Income | -25,322 | -21,637 | -23,740 | -30,785 | -24,503 |
| Interest Expense | 7,970 | 21,759 | 42,428 | 6,796 | 6,753 |
| Other Income | -6,785 | -1,941 | 1,166 | -7,625 | -4,169 |
| Pre-tax Income | -40,077 | -45,337 | -65,002 | -45,206 | -35,425 |
| Net Income Continuous | -40,077 | -45,337 | -65,002 | -45,206 | -35,425 |
| Net Income | $-40,077 | $-45,337 | $-65,002 | $-45,206 | $-35,425 |
| EPS Basic Total Ops | -0.06 | -0.07 | -0.10 | -0.08 | -0.06 |
| EPS Basic Continuous Ops | -0.06 | -0.07 | -0.11 | -0.08 | -0.06 |
| EPS Diluted Total Ops | -0.06 | -0.07 | -0.10 | -0.08 | -0.06 |
| EPS Diluted Continuous Ops | -0.06 | -0.07 | -0.11 | -0.08 | -0.06 |
| EBITDA(a) | $-24,254 | $-20,381 | $-22,588 | $-20,047 | $-22,739 |